4//SEC Filing
Schranz Jennifer 4
Accession 0001104659-20-028849
CIK 0001641640other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:31 PM ET
Size
4.8 KB
Accession
0001104659-20-028849
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-02-28$1.35/sh−301$406→ 169,949 total
Footnotes (1)
- [F1]The total reported in Column 5 includes 5,786 shares acquired under Nabriva Therapeutics plc's 2018 Employee Stock Purchase Plan ("ESPP") on April 30, 2019 and 5,759 shares acquired under the ESPP on October 31, 2019.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001735382
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:31 PM ET
- Size
- 4.8 KB